AstraZeneca Pharma India Limited Company Profile

Company Overview:

AstraZeneca Pharma India (AstraZeneca) is engaged in the manufacture and sale of pharmaceutical products. The company is into discovery, development and commercialization of medicines for various areas of healthcare, including cardiovascular and metabolic disease; cancer and respiratory; and inflammatory and autoimmune disease.

The company operates through two business segments: healthcare and clinical trial.

AstraZeneca, through healthcare segment is engaged in the manufacture and sale of pharmaceutical products.

The company's clinical trial segment, renders clinical trial services on pharmaceutical products to its group companies.

AstraZeneca offers medicines in various areas of healthcare including cardiovascular, diabetes, respiratory, maternal healthcare, oncology, infection, neuroscience and gastrointestinal. The company's cardiovascular medicines include Brilinta, Betaloc, Seloken XL, Imdur, Crestor, Seloram, Vigocil, Vigocil M, Nitract SR, Valfect, Olways, Olways H and Olways AM.

The company's diabetes medicines include Onglyza, Kombiglyze XR and Byetta. AstraZeneca offers respiratory medicines under the names Mit’s Linctus DX, Bricarex, Bricarex A, Bricacef, Bricacef DT, Bricacef PED, Bricanyl Syrup and Symbicort. The company's maternal healthcare products include Prostodin, Cerviprime and Partocin.

AstraZeneca offers oncology medicines under the names Arimidex, Nolvadex, Iressa, Zoladex, Casodex and Faslodex. The company's infection medicines include Meronem, Vancocin CP, Enclere, Enclere Forte and Remergin. AstraZeneca offers neuroscience medicines which include Xylocaine, Xylocaine Viscous, Sensorcaine, Sensorcaine Heavy, Diprivan and Naropin. The company's gastrointestinal products include Neksium Tablets and Neksium Injection.

Scope of the Report

• About the Company - Historical Details, Current Ownership Structure and basic overview of AstraZeneca Pharma India Limited in terms of revenue, net income, and operating income.
• Financials - Details about AstraZeneca Pharma India Limited listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.
• Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.
• Company SWOT Analysis - Outlines AstraZeneca Pharma India Limited’s strengths, weaknesses, and opportunities and threats facing the company.
• Recent Developments - Showcases AstraZeneca Pharma India Limited’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.
• Strategic Evaluation - Provides an overview of AstraZeneca Pharma India Limited’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.
• Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.

Key Questions Answered

• What domain does AstraZeneca Pharma India Limited operate and what are key points about it?
• What is the product / service portfolio of AstraZeneca Pharma India Limited?
• How has AstraZeneca Pharma India Limited performed financially from the 2013?
• How does AstraZeneca Pharma India Limited rank among its peers in terms of revenue and market share?
• What are AstraZeneca Pharma India Limited strengths and weaknesses and what opportunities and threats does it face?
• What are AstraZeneca Pharma India Limited’s main growth strategies and how successful has the company been at implementing them?
• What is the in-house technical capability of AstraZeneca Pharma India Limited? Where does it procure / outsource it?

Reasons to buy

•  Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own
• Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost
• 12 hour delivery time fulfilling your urgent requests as per your requirement
• On-demand customization options that can completely cater to your needs by focusing the report onto given specifics